Febrile neutropenia: transition towards a risk‐directed approach
AUTOR(ES)
Anoop, P
FONTE
BMJ Group
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2083713Documentos Relacionados
- Prevention of febrile neutropenia: use of prophylactic antibiotics
- Prevention of febrile neutropenia: use of granulocyte colony-stimulating factors
- Canine Cyclic Neutropenia: A STEM CELL DEFECT
- Evaluation of risk stratification strategies in pediatric patients with febrile neutropenia
- Neonatal sepsis with neutropenia: granulocytecolony stimulating factor (G-CSF)